0      0

SAT02 - Breakfast Activity/Non-CE Satellite Symposium: Intervening with Jakafi® (ruxolitinib) at the First Sign of Initial Systemic Treatment Failure in Chronic GVHD: A Real-World, Case-Based Resource for Advanced Practice Professionals - Incyte Corporation

‐ May 6, 2023 7:45am

Karolina Faysman, RN, MSN, AOCNP, DNP( c )

You must be logged in and own this session in order to post comments.